Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
79.74
-2.73 (-3.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Vaxcyte Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$127.71
Upside
+60.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | -82.44% | Feb 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +69.30% | Dec 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +75.57% | Nov 6, 2024 |
| Mizuho | Mizuho | Buy Maintains $113 → $163 | Buy | Maintains | $113 → $163 | +104.41% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $101 → $140 | Strong Buy | Maintains | $101 → $140 | +75.57% | Sep 4, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $106 → $153 | Buy | Maintains | $106 → $153 | +91.87% | Sep 3, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $108 → $129 | Strong Buy | Maintains | $108 → $129 | +61.78% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $95 → $140 | Strong Buy | Maintains | $95 → $140 | +75.57% | Sep 3, 2024 |
| BTIG | BTIG | Strong Buy Maintains $98 → $160 | Strong Buy | Maintains | $98 → $160 | +100.65% | Sep 3, 2024 |
| BTIG | BTIG | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +100.65% | Aug 7, 2024 |
| BTIG | BTIG | Strong Buy Reiterates $98 | Strong Buy | Reiterates | $98 | +22.90% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +19.14% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +19.14% | Jun 28, 2024 |
| B of A Securities | B of A Securities | Strong Buy Reiterates $101 | Strong Buy | Reiterates | $101 | +26.66% | Jun 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.